Nomura Asset Management CO LTD Avrobio, Inc. Transaction History

Nomura Asset Management CO LTD

  • $31.8 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 13, 2019
SELL
$13.21 - $27.29 $0 - $0
0 Closed
0 $0
Q1 2019

May 10, 2019
BUY
$12.46 - $22.05 $0 - $0
0 New
0 $0
Q1 2019

May 10, 2019
BUY
$12.46 - $22.05 $0 - $0
0 New
0 $0
Q4 2018

Feb 12, 2019
BUY
$15.43 - $32.7 $0 - $0
0 New
0 $0
Q3 2018

Nov 07, 2018
BUY
$26.95 - $52.7 $0 - $0
0 New
0 $0

Others Institutions Holding AVRO

# of Institutions
1
Shares Held
559K
Call Options Held
0
Put Options Held
0
View Full List

About AVROBIO, Inc.

AVRO Quotes by TradingView
  • Ticker AVRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,773,900
  • Description
  • AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...
More about AVRO
Track This Portfolio

Track Nomura Asset Management CO LTD Portfolio

Follow Nomura Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email